Bluejay Diagnostics Inc（BJDX）价格预测BJDXBluejay Diagnostics Inc

Alphio's BJDX stock price prediction model matches the current Bluejay Diagnostics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.86 (+1.39%). The 1-week path is $0.88 (+4.15%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Bluejay Diagnostics Inc (BJDX) is not a good buy right now due to its current price of $0.90, which is down 65.62% year-to-date, and an RSI of 33.798 indicating oversold conditions. The company's financial performance shows a troubling trend with a net income loss of $2,324,013 in Q2 2026, and a forward P/E ratio of 0, reflecting no earnings expectations. While there are positive developments such as a strong cash position of $9.6 million and completion of a pivotal clinical trial, the significant year-over-year decline of 83.58% in stock price raises substantial concerns. The main risk is the company's ongoing losses and lack of profitability, with an EPS of -1.12 reported in the last earnings, which could deter long-term investors.

Bluejay Diagnostics Inc (BJDX) last closed at $0.8491, gaining +0.19%. These facts feed the 1-day and 1-week BJDX price prediction above.